Objective -To investigate the use of plasma cell-free DNA (cfDNA) and nucleosome concentrations as prognostic biomarkers in canine sepsis. Design -Prospective, observational cohort study conducted from June 2015 to February 2016. Setting -University teaching hospital. Animals -Forty-five dogs with sepsis, 10 dogs with nonseptic systemic inflammatory response syndrome (nSIRS), and 15 healthy controls were consecutively enrolled and followed to hospital discharge. Patients were eligible for enrollment if they met ࣙ2 SIRS criteria and had a documented or highly suspected bacterial infection. Dogs <3 kg or with a known coagulopathy were excluded. Interventions -None.
Introduction
Sepsis is common in dogs and is associated with substantial morbidity and a high risk of death, with reported mortality rates ranging from 20% to 68%. [1] [2] [3] Sepsis is a clinical syndrome defined as the systemic inflammatory response to infection that is diagnosed by documenting the hallmarks of a systemic inflammatory response syndrome (SIRS; fever, tachycardia, tachypnea, and leukocytosis) and identifying an infective agent. Commonly used SIRS criteria are sensitive for sepsis diagnosis, 2 but lack specificity and have limited prognostic ability. 4 Illness severity in septic dogs can be assessed using scoring systems, such as Survival Prediction Index-2, 5 Acute Patient Physiology and Laboratory Evaluation (APPLE), 6 and the Sequential Organ Failure Assessment score. 7 While these methods accurately quantify the consequences of sepsis, they are insensitive to the underlying immune dysfunction that characterizes sepsis. Biomarkers have been widely evaluated in sepsis in an attempt to provide accurate diagnosis and prognostication. 8 The ideal biomarker provides biologic insight into the disease process and improves our understanding of pathogenesis. Acute phase reactants such as serum amyloid A and C-reactive protein are increased in canine sepsis but are not prognostic. 9, 10 Increased procalcitonin concentrations are prognostic in people with septic shock, 11, 12 and procalcitonin may be superior to C-reactive protein in this regard, but efforts to measure it in dogs have been unsuccessful. 13 Identification of a biomarker that can be rapidly measured patient-side and that correlates with illness severity and prognosis in canine sepsis would advance the pursuit of individualized medicine.
In people, increased plasma concentrations of cellfree DNA (cfDNA) have been demonstrated in association with thermal burns, cancer, and trauma. [14] [15] [16] This cfDNA may originate from apoptotic cells, necrotic tissue, or from neutrophil extracellular traps (NETs). [17] [18] [19] These NETs are a host-defense mechanism, comprised of extracellular DNA decorated with histones and bactericidal proteins including elastase and myeloperoxidase, produced by activated neutrophils that ensnare, trap, and opsonize invading bacteria. 20 Where the rate of neutrophil extracellular trap formation (NETosis), apoptosis, or necrosis is high, and the mechanisms responsible for removal become saturated, the plasma concentrations increase. 21 In addition to being an indicator of nature of the disease process and its severity, it has been demonstrated that NET formation may directly contribute to pathogenesis in sepsis through the phenomenon of immunothrombosis, 22 while cfDNA can inhibit plasmin-mediated fibrinolysis. 23 As such, cfDNA has the potential to provide biologic insight into the extent and nature of the innate immune response to infection and inflammation.
Increased cfDNA concentrations have also been detected in the blood of critically ill people and in those with sepsis, 24, 25 and increased cfDNA concentrations are prognostic in people with bacteremia. 26, 27 In febrile human ICU patients, cfDNA measurement has high negative and positive predictive values, wherein normal cfDNA concentrations exclude infection, while high concentrations predict mortality. 28 Recently, we identified increased plasma concentrations of cfDNA in dogs with trauma, cancer, and sepsis using direct fluorescence detection assays. 29 Nucleosomes are complexes formed by DNA and histone proteins that are released into circulation during cell death and cellular damage, such as apoptosis and necrosis. 30 They can also be due to the process of NET formation. As such, cfDNA and nucleosomes share potential origins, but are distinct entities, 31 with differential potential for immune cell activation through pattern recognition receptors. 30 Measuring both biomarkers may provide better insights into the disease process than either alone. 31 People with septic shock have significantly higher nucleosome concentrations than patients with sepsis, noninfectious SIRS, or fever. 32 In people, plasma nucleosome concentrations distinguish septic from nonseptic critically ill patients and correlate with the severity of immunosuppression and with organ dysfunction. 21 Nucleosome concentrations are increased in horses with colic, 33 but to the authors' knowledge, nucleosome concentrations in canine sepsis have not been evaluated to date.
Therefore, the purpose of this study was to investigate the utility of plasma cfDNA as a prognostic biomarker in canine sepsis. We aimed to determine if plasma cfDNA in dogs with sepsis was associated with plasma nucleosome concentrations and to determine if plasma nucleosome concentrations are prognostic in dogs with sepsis. We hypothesized that in dogs with sepsis, plasma cfDNA concentrations are positively associated with illness severity and are higher in nonsurvivors, and that plasma nucleosome concentrations are positively associated with cfDNA concentrations and are higher in nonsurvivors.
Material and Methods

Animals
Dogs admitted with a diagnosis of bacterial sepsis were eligible for inclusion. Bacterial sepsis was diagnosed based on established SIRS criteria 2 and the presence of suspected or confirmed bacterial infection. To maximize patient safety by reducing likelihood of bleeding 504 or iatrogenic anemia patients with bodyweight <3 kg, prothrombin or activated partial thromboplastin times >150% prolonged or platelet count <30.0 × 10 9 /L (<30,000/L) were excluded. Dogs that met inclusion criteria in which bacterial infection was suspected but not subsequently confirmed were reclassified as noninfectious SIRS (nSIRS). Dogs with SIRS and a confirmed bacterial infection were classified as septic. Respective primary clinicians determined all aspects of patient management. Biomarker concentrations were not available to primary clinicians. Fifteen healthy staff-owned dogs weighing >3 kg were enrolled as controls. These dogs were eligible if they had no history or evidence of recent or chronic medical conditions and had not received any medication, except for routine preventative healthcare, within the preceding 3 months. Dogs were classified healthy on the basis of history, physical examinations, and complete blood count and serum chemistry results. This study was approved by the local Institutional Animal Care and Use Committee (2014-0053-01) and was undertaken with written informed client consent.
Data collection
Signalment, previous medical history, and physical examination findings at hospital admission were recorded. Noninvasive blood pressure measurement a and pulse oximetry b were performed and mentation, Modified Glasgow Coma Scale, and ultrasound body cavity fluid scores were measured at admission to enable calculation of the Acute Patient Physiologic and Laboratory Evaluation (APPLE full and APPLE fast ) scores. 6 Blood samples were collected at enrollment for blood culture, blood lactate, c complete blood count, d serum biochemistry, e and cfDNA measurement. f The final diagnosis and source of infection in septic patients and the underlying disease considered the trigger for systemic inflammation in nSIRS dogs were also recorded. Outcome was recorded as survival to hospital discharge, death, or euthanasia for disease severity. Dogs euthanized for financial limitations were excluded from analyses. Citrated plasma was generated by centrifugation of whole blood for 10 minutes at 1,370 × g.
g After centrifugation, plasma was decanted into polypropylene freezer tubes, h by pipetting. Some plasma was deliberately left in the tube to minimize the risk of disturbing the buffy coat. Concentrations of cfDNA in citrated plasma were measured immediately following sample collection using a benchtop fluorimeter and relevant reagents, f,i according to the manufacturers' instructions. 26, 27 The remainder of the citrated plasma was frozen at -80°C for batched analysis of plasma nuclesomes. Concentrations of plasma nucleosomes were analyzed using a commercial ELISA scaled against pooled normal canine plasma.
33,j
Statistical methods A priori sample size calculations were performed using pilot data.
k Mortality in the pilot study was 40% (6/15). The mean ± SD cfDNA concentration in nonsurvivors was 1,204 ± 1,183 g/mL, compared 529 ± 347 g/mL in survivors. 29 We estimated that 45 dogs with sepsis at 40% mortality would enable detection of a 2-way difference with 80% power at P < 0.05. We did not perform sample size calculations for the nSIRS group. Prior to test selection, data were assessed for normality by assessment of histograms, calculation of skewness and kurtosis, and with the D'Agostino Pearson test. Descriptive statistics were calculated as appropriate. Most variables were not normally distributed and hence continuous variables were compared between groups with the Kruskal-Wallis test, with Dunn's adjustment for multiple comparisons or with the Mann-Whitney U-test. Summary data are presented as median (minimum-maximum). Associations between cfDNA concentrations and nucleosomes, leukocyte count, neutrophil count, and APPLE scores were evaluated by Deming regression and calculation of Spearman's correlation coefficients (r s ). All analyses were performed using commercial software.
l Alpha was set at 0.05.
Results
Demographics
Forty-five dogs with sepsis, 10 dogs with noninfectious SIRS (nSIRS), and 15 healthy dogs were enrolled in the study. Among septic dogs, there were 6 Labrador Retrievers, 6 Staffordshire Bull Terriers, 4 English Bulldogs, and 4 mixed breed dogs. Various other breeds were also represented (all n = 1). There were 20 males and 25 females and 47% (21/45) were intact. Median age was 5.5 years (0.6-12.0 years) and median weight was 30.0 kg (5.6-74.0 kg). The nSIRS group included 2 Dachshunds and 8 dogs of various breeds (all n = 1). Two were male and 8 were female. Sixty percent (6/10) were intact. Median age was 6.5 years (0.8-10.0) and median weight was 25.5 kg (5.3-34.5). Most healthy control dogs were mixed breed. Seven dogs were male and 8 were female. Thirteen percent (2/15) were intact. Median age was 3.6 years (1.1-12.0) and median weight was 24.8 kg (3.5-59.2). Age, weight, and proportion of males versus females were not significantly different between the 3 groups. However, there were significantly fewer intact dogs in the healthy groups compared to the patients (P = 0.03).
Dogs with sepsis had a median APPLE full score of 30 (11-52) and a median APPLE fast score of 22 at the time of presentation. In that group, the mortality rate was 22.2% (n = 10) of which 9 (90%) were euthanized and 1 (10%) died. Among the nonsurvivors that died or were euthanized, 4 were euthanized at presentation for poor prognosis and 6 died or were euthanized after a mean of 1.2 day of hospitalization (1-3 days) because of worsening clinical signs or development of complications. Nonsurvivors had significantly higher APPLE full scores than survivors (38.5 vs 27, P = 0.0018) and significantly higher APPLE fast scores (29 vs 20, P < 0.0001). Survivors were hospitalized for a median 4 days (1-7). The most frequent disease processes in the sepsis group were pneumonia (n = 14), septic abdomen (n = 11), pyometra (n = 10), abscess (n = 3), mastitis (n = 2), and one of each of orchitis, osteomyelitis, urinary tract infection, dermatitis, and septic arthritis. Fourteen (31.1%) of the septic dogs had a positive blood culture. The most common bacteria isolated were Escherichia coli (n = 7) and Streptococcus canis (n = 3). Other bacteria isolated included alpha-hemolytic Streptococcus species (n = 1), Enterococcus faecalis (n = 1), Enterobacter cloacae (n = 1), and Staphylococcus pseudintermedius (n = 1). Twenty-two septic dogs (48.9%) were seen by their primary care veterinarian prior to enrollment and 20/22 (90.9%) had been treated with antimicrobials. Among those treated with antimicrobials, 6/20 (30.0%) had a positive blood culture. The median duration of clinical signs prior to presentation was 4 days (1-42). All nSIRS dogs and healthy controls had a negative blood culture. Five nSIRS dogs received antibimicrobials prior to enrollment.
Point-of-care cfDNA cfDNA data are summarized in Figure 1 . Compared to healthy controls, plasma cfDNA concentrations were significantly increased in dogs with sepsis and nSIRS (P < 0.0001 and P = 0.0034, respectively). However, cfDNA concentrations in septic dogs were not significantly different from those of nSIRS dogs. In the sepsis group, cfDNA concentrations were significantly higher in dogs with a positive blood culture compared to dogs with a negative blood culture (P = 0.0299). There were no associations between cfDNA concentration and lactate, APPLE full score, leukocyte count, or neutrophil count. Concentrations of cfDNA were positively correlated with APPLE fast score (r s = 0.335, P = 0.025), however. In the sepsis group, survivors had significantly higher neutrophil counts (13.2 × 10 9 /L, 0.2-48.4) compared to nonsurvivors (3.6 × 10 9 /L, 0.0-23.9; P = 0.0193). There was no significant difference in the cfDNA concentrations between survivors and nonsurvivors (P = 0.1159), but nonsurvivors had significantly higher cfDNA concentrations per 1,000 neutrophils ( Figure 2 ) than survivors (P = 0.0083).
Nucleosomes
Nucleosome concentrations ( Figure 3) were significantly higher in septic dogs compared to healthy controls Cell-free DNA concentrations were significantly higher in dogs with sepsis and in dogs with nSIRS than those in healthy dogs (P < 0.0001 and P = 0.0034, respectively).
(P = 0.0071). There were no significant differences in nucleosome concentrations between septic and nSIRS groups or between nSIRS dogs and healthy controls (P = 0.768 and P = 0.141, respectively). There was a weak but significant positive association between cfDNA and nucleosome concentrations (r s = 0.266, P < 0.0258; Figure 4) . In the sepsis group, nucleosome concentrations were not significantly different between survivors and nonsurvivors (P = 0.9301).
Discussion
Consistent with our previous study, 29 dogs with sepsis had significantly higher cfDNA concentrations compared to healthy controls. In people, cfDNA concentrations are higher in patients with septic shock compared to sepsis and are as effective as procalcitonin in the diagnosis of infection. 28 In contrast, although dogs ultimately classified as nSIRS had higher concentrations of cfDNA compared to healthy dogs, there was no significant difference between dogs with sepsis and those with nSIRS. The cause of this distinction is uncertain, but plausible explanations include species differences, a failure to recognize an infection in dogs with nSIRS leading to group misclassification or the small number of nSIRS dogs included in our study, which was not powered to identify a difference between the cfDNA concentrations in sepsis and nSIRS. A further possibility is that our sepsis definition depends on SIRS criteria, which were designed to be sensitive rather than specific. 2 Our definition of sepsis was based on that generated by the 2001 consensus conference. 34 We classified as septic any dog that satisfied SIRS criteria and had an infection, but it is possible some of these dogs did not truly have systemic inflammation. Adopting the new sepsis-3 definition 35 would likely lead to the reclassification of some dogs in our septic group. At present, there is no consensus on whether the sepsis-3 definition is applicable to veterinary medicine, but it is possible cfDNA concentrations might better distinguish dogs with nSIRS from those with sepsis as defined by the sepsis-3 definition. Dogs with positive blood cultures had higher plasma concentrations of cfDNA than dogs with negative blood cultures, suggesting that cfDNA concentrations may be a useful indicator of bacteremia. We speculate that this is due to increased intravascular NETosis in dogs with bacteremia. In mouse models of sepsis, most cfDNA is host-derived making it less likely that the dogs with bacteremia had microorganism-derived DNA free in circulation, although sequence analysis would be necessary to confirm this. 18 Irrespective, point-of-care measurement of cfDNA might provide an early warning of the presence of bacteremia and enable early treatment intensification.
Unexpectedly, we found no association between cfDNA concentrations and APPLE full score in septic dogs, although we did find a positive correlation between APPLE fast score and cfDNA. A recent study suggested that the APPLE fast score may be a better guide to illness severity in canine sepsis than the full score. 36 It is also possible that the limited disease severity in our population may have made it more difficult to detect an association between cfDNA concentrations and APPLE full score, since only 22/45 (48.9%) had an APPLE full score >30 and our overall mortality rate was 22.2%. Defined as sepsis with hypotension despite adequate volume resuscitation, only 3 dogs in our cohort had septic shock, 34 while according to the recent sepsis-3 definition, most dogs in our study would not be classified as septic (ie, they did not have organ dysfunction). 35 Dogs were likely enrolled in this study at various stages in their disease process and some had already received therapy with antibiotics or fluid resuscitation. These factors may have contributed to the lack of association between cfDNA concentrations and APPLE full scores. Increased plasma cfDNA concentrations may be caused by increased release of cfDNA or decreased clearance. The mechanisms of metabolism and clearance of cfDNA from plasma are not fully understood, but likely involve the liver, spleen, and kidneys. 26, 37 Since the metabolism and clearance of cfDNA are incompletely understood, it is possible that some patients had alterations in cfDNA clearance that affected measured concentrations without altering illness severity scores.
cfDNA concentrations were not significantly different between survivors and nonsurvivors in this study, which may be due in part to the high percentage of nonsurvivors that was euthanized. Although we attempted to eliminate dogs euthanized for financial reasons, it is possible that some of the dogs euthanized may have survived with continued therapy, confounding the relationship between cfDNA concentrations and outcome. Various host cells, including leukocytes and endothelial cells, can release cfDNA. 18, [38] [39] [40] NETosis is a putative mechanism for the high concentrations of cfDNA found in septic dogs. Since circulating nucleosomes are a plausible marker of NET formation, 22 we examined the link between cfDNA and NETosis in sepsis by measuring nucleosome concentrations and by assessing the relationship between neutrophil counts and cfDNA concentrations. We found a weak positive association between cfDNA and nucleosome concentrations in septic dogs, but no association between leukocyte or neutrophil counts and cfDNA. These findings suggest that the high plasma cfDNA concentrations we identified may have sources other than NETs. This is consistent with data from a mouse sepsis model, where depletion of neutrophils did not decrease blood cfDNA concentrations suggesting that alternative sources of cfDNA predominate in that model. 18 We speculate that the cfDNA we identified in dogs with sepsis originates in part from extracellular trap formation and in part from apoptosis, but further work will be required to answer this question.
Consistent with previous studies, we found that septic nonsurvivors had lower neutrophil counts compared to survivors. We speculated that if the cfDNA in sepsis was derived in part from NETosis, then patients producing high concentrations of cfDNA despite low neutrophil counts might have a poorer prognosis. Indeed, the ratio of cfDNA to neutrophil count was higher in nonsurvivors than survivors. In these patients, low neutrophil counts may be a consequence of overwhelming 508 demand, NETosis, or a failure of adequate production. Neutropenia as represented by a degenerative left shift has previously been identified to be a negative prognostic indicator in dogs, potentially as a marker of disease severity and as a mechanism by which severely ill patients have insufficient means to protect themselves from bacterial infection. 41 In a post-hoc analysis of our data, there was no significant association between a degenerative left shift and outcome (data not shown).
Nucleosome concentrations were significantly higher in septic dogs compared to healthy dogs but there was no difference between the sepsis and nSIRS groups. Comparison of the median values for the nSIRS and the sepsis groups (Figure 3) suggests this may be a type II error, however, due to the variation in the nucleosome concentrations within the nSIRS group and the comparatively small sample size. Increased concentrations of circulating nucleosomes have been demonstrated in people with disorders characterized by systemic inflammation without an underlying infectious cause, like immune-mediated diseases, 42 pancreatitis, 43 and cancer. 44 The lack of difference in the concentrations of nucleosomes between septic and nSIRS dogs may be due to the presence of apoptosis, necrosis, and possibly NETosis in patients with systemic inflammation independent of the infectious or noninfectious nature of the inflammatory process. Furthermore, in the sepsis group, there was no difference in the nucleosome concentrations between survivors and nonsurvivors, suggesting that this biomarker may not be a good predictor of outcome. This may be explained by the overall mild illness severity of our septic dogs and the high number of nonsurvivors that were euthanized.
We recognize our study has limitations. cfDNA and nucleosome concentrations were measured only at enrollment. Dogs were presented at different times during the course of disease and since the kinetics of cfDNA and nucleosome release in sepsis are unknown, but are likely dynamic, this may have affected measured concentrations in an unpredictable manner. Serial evaluation of changes in cfDNA and nucleosome concentrations over time in response to therapy is underway and may help define the role of those biomarkers in the prediction of outcome. Some of our patients received antibiotics prior to study inclusion, which may have affected the measured cfDNA and nucleosome concentrations and illness severity scores, confounding our results. We prepared citrated plasma by centrifugation at 1,370 × g prior to point-of-care measurement. Additional centrifugation steps were not performed prior to cfDNA measurement because this analysis was performed patient-side in our emergency room. Prior work found no difference between cfDNA measured after an initial spin at 1,600 × g followed by a second spin at 16,000 × g compared to 1,600 × g alone. 45 We feel that it is therefore unlikely our sample preparation method affected our results, particularly as the same method was used for all cases and controls. There was a significant difference between the number of intact dogs in our control population compared to our cases. It is unclear what, if any, effect this would have on cfDNA or nucleosome concentrations, and there is no current literature evaluating this question. Post-hoc analyses of the septic population suggested that neutering status had no impact on cfDNA concentrations, however (data not shown).
The nucleosome assay we employed was designed for assessment of apoptosis in cultured cells and hence does not have a reference standard to enable absolute concentrations to be established. To circumvent this, we scaled the concentrations of plasma nucleosomes against pooled frozen plasma from healthy control dogs. This approach assumes that our blood donor population had normal nucleosome concentrations and precludes reporting an actual value for the nucleosome concentrations in our septic dogs. Nucleosome concentrations were batch analyzed within 9 months of sample collection. A study on the effect of long-term sample storage on human serum nucleosome measurements suggests that up to 9 months is an acceptable storage time, although it is not known if the same is true in dogs. 46 In that study, serum was stabilized with 10 mM EDTA prior to storage, a step that we did not undertake because we measured nucleosome concentrations on citrated plasma. Other investigators have measured nucleosome concentrations in citrated plasma, suggesting that the choice of sample type is unlikely to have affected our results. 47 The nucleosome ELISA assay we used was recently used for the detection of nucleosomes in dogs with immunemediated hemolytic anemia. 48 That study identified high concentrations of circulating nucleosomes in dogs with IMHA but suggested that this apparent increase be viewed with caution due to positive interference from hemolysis and icterus. Hemolysis and icterus were present in some of our samples, which may have affected our results. In a post-hoc reanalysis of our data after excluding 3 dogs with bilirubin >0.4 mg/dL, and 7 dogs with detectable hemolysis (hemoglobin >60 mg/dL), 49 the association between cfDNA and nucleosomes was no longer significant (r s = 0.250, P = 0.0541). As such, we feel that the association of cfDNA and nucleosome concentrations and the lack of a difference in nucleosome concentrations between sepsis and nSIRS patients should be replicated in other populations before firm conclusions regarding this biomarker in canine sepsis are reached. Additional reanalyses of the cfDNA data after excluding these patients did not alter any of the relationships between cfDNA concentration and bac-C Veterinary Emergency and Critical Care Society 2018, doi: 10.1111/vec.12773 teremia, cfDNA concentration and outcome, or alter the identified differences in cfDNA concentration between groups (data not shown).
Other potential sources of confounding variables are present in our study. Some of our patients may have had comorbidities that affected cfDNA concentrations distinct from their septic processes. cfDNA concentrations may be increased with cancer, 29 and it is possible that undiagnosed neoplasia in our sepsis group contributed to the increased cfDNA concentrations. One septic dog enrolled in the study developed aspiration pneumonia within 24 hours of gastropexy for correction of gastric dilation-volvulus (GDV). Gastric necrosis can occur in this syndrome and could lead to cfDNA release contributing to the measured concentrations in this patient. Additional investigations focused on cfDNA in gastric dilation-volvulus syndrome may be warranted.
In summary, this study demonstrates that plasma cfDNA concentrations can be measured at the pointof-care and that septic dogs have higher cfDNA concentrations compared to healthy dogs. Plasma cfDNA concentrations may be a useful indicator of bacteremia, and dogs with neutropenia and high cfDNA concentrations have a higher risk of death. Compared to healthy controls, nucleosome concentrations are significantly higher in dogs with sepsis and nSIRS, although they are not prognostic. The limited association of cfDNA and nucleosome concentrations allows for sources of cfDNA other than NETosis in septic dogs and hence further studies on the origin and kinetics of cfDNA release in canine sepsis appear warranted. 
Footnotes
